Green Cross Of S. Korea Said Freed To Take Orders For H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
South Korea's Green Cross said its H1N1 influenza vaccine GCFlu has been approved for marketing by the Korea FDA, ending the nation's reliance on imports and freeing the company to take orders for its drug. Green Cross said it would have produced by the end of July enough doses for 3.3 million, rising to 5 million people covered by the end of the year. South Korea thus becomes the world's 12 vaccine producer. (Click here for more